Skip to content
Riskpilot
← Back to search
Sign in
Get full access
INSTITUTE OF IMMUNOSYNERGETICS ApS
APS
Dissolved
CVR 13869332
Strandvejen 114A, 8000
Aarhus C
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
· NACE 721900
Est. 1990
— employees
Watchlist
Share
Denmark
/
Companies
/
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
/
INSTITUTE OF IMMUNOSYNERGETICS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
Income statement
DKK thousands
Item
2012
2013
2014
2015
Revenue
-18
-20
-4
-2
Staff expenses
-0
-0
-0
-0
EBITDA
-18
-20
-4
-2
Depreciation & amort.
-0
-0
-0
-0
EBIT
-18
-20
-4
-2
Net financials
36
13
15
6
Profit before tax
18
-7
12
5
Tax
5
-2
4
13
Net profit
13
-5
8
-8
Balance sheet
DKK thousands
Item
2012
2013
2014
2015
Total assets
409
403
407
392
Equity
388
383
390
332
Long-term debt
0
0
0
0
Short-term debt
21
20
16
60
Total debt
21
20
16
60
Financial ratios
5-year trend
EBITDA margin
-166200.0%
This company
15.8%
Market median
-1051999% vs market
2012
2015
Equity ratio
84.7%
This company
38.2%
Market median
+122% vs market
2012
2015
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
2012
2015
Net profit margin
-829100.0%
This company
8.1%
Market median
-10235902% vs market
2012
2015
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2012
2015
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2012
2015
Annual reports & filings
Annual report 2015
Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
View
PDF
More on INSTITUTE OF IMMUNOSYNERGETICS ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
